Business
HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches CBD Topical and Beauty Products at Gelson’s Market
HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches CBD Topical and Beauty Products at Gelson’s Market.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n SAN DIEGO, July 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has launched a retail partnership with Gelson’s Market to sell the Company’s cannabidiol (CBD) topical and beauty products throughout Southern California.  “When the founders of HempMeds started the company in 2012, retailers didn’t want to work with us, or any CBD companies for that matter,” said Raul Elizalde, Co-CEO of HempMeds®. “The taboo of anything cannabis related and the lasting effects of the War on Drugs made it nearly impossible to sell to the general population but as more research was conducted into its potential benefits, consumers started demanding CBD at the places where they were already shopping.” “As we evolve and grow, we look forward to working with retail partners such as Gelson’s that have a similar mission and vision of bringing high-quality natural products to market,” added HempMeds® Co-CEO Caroline Heinz.  Gelson’s Market will carry the following HempMeds® CBD-infused products: Real Scientific Hemp Oil™ (RSHO™) Salve Dixie Botanicals® + Surface® CBD-Infused SPF50 SunscreenHempMeds® Hydrating & Purifying Hemp Shampoo HempMeds® Nourishing Hemp Conditioner HempMeds® Revitalizing Hemp Body Wash HempMeds® Hydrating & Soothing Hemp Body LotionHempMeds® Active Relief Cooling Roll-On HempMeds® Essential Body Oil  All of HempMeds® products feature CBD derived from high-quality industrial hemp. The hemp is free of pesticides and herbicides and is Triple Lab Tested at every stage of production for quality, consistency and safety.  “For 2020, Nielson estimates that the hemp-derived CBD market could reach $2.5 billion, providing us with significant evidence that this is something our customers are looking to purchase,” said John Bagan, Chief Merchandising Officer for Gelson’s. “We decided to partner with HempMeds because of ...